Showing results (981-990 of 1,095) with videos related to
Sort By:
Pageof 110
Cells|October 27, 2022
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung CancerAnnapaola Mariniello, Fabrizio Tabbò, Davide Indellicati, et al.Cancers|June 2, 2021
Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural MesotheliomaDario P Anobile, Paolo Bironzo, Francesca Picca, et al.Journal of the National Cancer Institute|March 6, 2003
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trialCesare Gridelli, Francesco Perrone, Ciro Gallo, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 23, 2017
Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter surveyS Carnio, D Galetta, V Scotti, et al.Scientific Reports|May 12, 2023
Consensus clustering methodology to improve molecular stratification of non-small cell lung cancerL Manganaro, S Bianco, P Bironzo, et al.Lancet (London, England)|September 17, 2024
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trialJonathan D Spicer, Marina C Garassino, Heather Wakelee, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 15, 2016
Clinicopathologic Features of Advanced Squamous NSCLCMark A Socinski, Coleman Obasaju, David Gandara, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 1, 2026
Patient-Reported Outcomes with Consolidation Durvalumab Versus Placebo Following Concurrent Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer: Results from the Phase 3 ADRIATIC TrialSilvia Novello, Ying Cheng, David Spigel, et al.Cancers|January 7, 2021
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung CancerCaterina De Luca, Francesco Pepe, Antonino Iaccarino, et al.JTO Clinical and Research Reports|September 30, 2021
Efficacy and Safety of Rociletinib Versus Chemotherapy in Patients With <i>EGFR</i>-Mutated NSCLC: The Results of TIGER-3, a Phase 3 Randomized StudyJames Chih-Hsin Yang, Karen L Reckamp, Young-Chul Kim, et al.Pageof 110